CVS Health Corporation (CVS)
| Market Cap | 118.41B +19.0% |
| Revenue (ttm) | 412.65B +7.4% |
| Net Income | 4.89B +7.9% |
| EPS | 3.82 +6.3% |
| Shares Out | 1.28B |
| PE Ratio | 24.26 |
| Forward PE | 11.40 |
| Dividend | $2.66 (2.87%) |
| Ex-Dividend Date | Oct 22, 2026 |
| Volume | 14,268,271 |
| Open | 91.78 |
| Previous Close | 90.39 |
| Day's Range | 91.00 - 92.64 |
| 52-Week Range | 69.51 - 110.68 |
| Beta | 0.60 |
| Analysts | Strong Buy |
| Price Target | 115.48 (+24.74%) |
| Earnings Date | Nov 4, 2026 |
About CVS
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care prov... [Read more]
Financial Performance
In 2025, CVS Health's revenue was $399.83 billion, an increase of 7.87% compared to the previous year's $370.66 billion. Earnings were $1.77 billion, a decrease of -61.68%.
Financial StatementsAnalyst Summary
According to 27 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $115.48, which is an increase of 24.74% from the latest price.
News
Aetna deems IB-Stim by NeurAxis medically necessary
CVS Health’s (CVS) Aetna in a clinical policy bulletin announced that it considers percutaneous electrical nerve field stimulation with IB-Stim medically necessary durable medical equipment for the tr...
CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
New research study will explore the realities and opportunities of midlife and inform an upcoming documentary WOONSOCKET, R.I., Oct 15, 2026 /PRNewswire/ -- CVS Health ® (NYSE: CVS) today announced a ...
CVS to pay $315 million settlement to resolve DOJ opioid lawsuit
CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions of highly addictive...
MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards
Approximately 80 percent of surveyed locations offer primary care, now available at more than 65 percent of MinuteClinic locations. WOONSOCKET, R.I.
CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims
The U.S. government alleged that CVS knowingly filled prescriptions for controlled substances that lacked a legitimate medical purpose, weren't valid or weren't issued in the usual course of professio...
CVS’s Aetna announces 69% of MA members are in ’27 plans rated 4 stars, up
Aetna, a CVS Health (CVS) company, announced that more than 69% of its Medicare Advantage, MA, members are in 2027 plans rated 4 stars or higher by the Centers for…
CVS Health price target lowered to $112 from $119 at Leerink
Leerink lowered the firm’s price target on CVS Health (CVS) to $112 from $119 and keeps an Outperform rating on the shares. The firm says CVS’ setup for Q3 looks…
CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
NEW ORLEANS, Oct. 9, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
CVS Stock Dips After Drop in Medicare Advantage Plan Ratings
Aetna, the insurance arm of CVS Health, saw its four-star or higher plans lose ground in the latest federal ratings.
CVS Star ratings came in weaker than expected for 2027, says TD Cowen
TD Cowen analyst Charles Rhyee says CVS Health’s (CVS) Star ratings came in weaker than expected for 2027, with 70% of MA enrollment in 4-star rated plans, down from 82%…
Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
HARTFORD, Conn., Oct 8, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that more than 69 percent of its Medicare Advantage (MA) members are in 2027 plans rated 4 stars...
Managed Care Organization stock moving after CMS releases Star ratings
CVS Health (CVS) is down almost 5% in after-hours trading, UnitedHealth (UNH) fell over 1%, and Alignment Healthcare (ALHC) dropped over 20%, while Humana (HUM) soared 15% Other publicly traded…
CVS Health’s Aetna announces 2027 Medicare products
Aetna, a CVS Health (CVS) company, announced its 2027 Medicare products with choices designed to support older adults with a wide range of health needs. The company is expanding the…
CVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area
Pharmacy-focused sites are opening in select communities to help increase access to pharmacy care WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled its first pharma...
CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
Eligible patients can receive MMR vaccinations at more than 530 CVS Pharmacy® locations across New York and at MinuteClinic® locations WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- As New York respon...
CVS Health price target lowered to $110 from $120 at BofA
BofA analyst Allen Lutz lowered the firm’s price target on CVS Health (CVS) to $110 from $120 and keeps a Buy rating on the shares. CVS recently flagged changes to…
CVS Health to hold third quarter 2026 earnings conference call
WOONSOCKET, R.I., Oct. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 4, 2026, at 8:00 a.m.
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
Plans designed to provide member value and access to care: $0 copays on Tier 1 drugs and covered vaccines at in-network pharmacies* $0 copays for annual physicals, colonoscopies and mammograms at in-n...
CVS extensions ‘a clearing event’ for McKesson, Cardinal Health, says BofA
BofA reiterates Buy ratings on McKesson (MCK) and Cardinal Health (CAH) after both companies announced deals to extend distribution agreements with CVS Health (CVS). The extension of the CVS contracts...
McKesson enters agreement to extend distribution agreements with CVS Health
McKesson Corporation (MCK) signed an agreement in principle to extend its partnership with CVS Health (CVS) to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and...
Cardinal Health enters LOI to extend distribution agreements with CVS Health
Cardinal Health (CAH) has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health (CVS) through June 30, 2032, reflecting the continuation of Cardinal…
CVS Health declares quarterly dividend
WOONSOCKET, R.I., Sept. 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per ...
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide
CVS Pharmacy® and MinuteClinic® offer MMR vaccinations to help protect eligible patients and communities WOONSOCKET, R.I., Sept. 23, 2026 /PRNewswire/ -- Following the Tennessee Department of Health's...
CVS Health's Aetna to streamline cancer treatment approvals
CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment for cancer patients to only one medical prior authorization process early on, the compan...